Judicious evaluation of adverse drug reactions: Inaccurate assessment of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor-induced muscle injury

Pharmacotherapy

Volumn 19, Issue 2, 1999, Pages 232-235

  Dietz, Brenda L ^a,b   Oberg, Kristin C ^b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ATORVASTATIN; CORTISONE; GEMFIBROZIL; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; LISINOPRIL; NICOTINIC ACID; PARACETAMOL; SIMVASTATIN; TRIAMTERENE;

ADULT; AGED; ARTICLE; CASE REPORT; COMPARTMENT SYNDROME; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; MALE; MUSCLE INJURY; RHABDOMYOLYSIS; TENNIS ELBOW;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; DIAGNOSTIC ERRORS; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MUSCULAR DISEASES; PYRROLES; RHABDOMYOLYSIS; SIMVASTATIN;

EID: 0032912775     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.3.232.30924     Document Type: Article

References (23)

1. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard medical practice study II. N Engl J Med 1991;324:377-84.
2. Rossi AC, Knapp DE. Discovery of new adverse drug reactions: a review of the Food and Drug Administration's spontaneous reporting system. JAMA 1986;252:1030-3.
3. Busto U, Naranjo CAU, Sellers EM. Comparison of two recently published algorithms for assessing the probability of adverse drug reactions. Br J Clin Pharmaol 1982;13:223-7.
4. Lanctot KL, Naranjo CA. Comparison of the Bayesian approach and a single algorithm for assessment of adverse drug events. Clin Pharmacol Ther 1995;58:692-8.
5. Venning GR. Identification of adverse reactions to new drugs. II (continued). How were 18 important adverse reactions discovered and with what delays? Br Med J 1983;286:365-8.
6. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
7. Matsen FA, Rorabeck CH. Compartment syndromes. Instr Course Lect 1989;38:463-72.
8. Barnes M. Diagnosis and management of chronic compartment syndromes: a review of the literature. Br J Sports Med 1997;31:21-7.
9. Manoli A. Compartment syndromes of the foot: current concepts. Foot Ankle 1990;10:340-4.
10. Abramowitz AJ, Schepsis AA. Chronic exertional compartment syndrome of the lower leg. Orthop Rev 1994;23:219-25.
11. Mavor GE. The anterior tibial syndrome. J Bone Joint Surg 1956;38B:513-17.
12. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5.
13. Meyboom RH, Hekster YA, Egbert AC, Gribriau FW, Edwards IR. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 1997;17:374-89.
14. Burnakis TG. Inaccurate assessment of drug-induced thrombocytopenia: reason for concern. Ann Pharmacother 1994;28:726-9.
15. Hsu I, Spinler SA, Johnson NE. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Ann Pharmacother 1995;29:743-59.
16. Colosimo RJ, Nunn-Thompson C. HMG-CoA reductase inhibitors. Formulary 1993;18:21-31.
17. Poels PJE, Gabreëls FJM. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg 1993;95:175-92.
18. Pendergast BD, George CF. Drug-induced rhabdomyolysis -mechanisms and management. Postgrad Med J 1993;69:333-6.
19. Bizzaro N, Bagolin E, Milani L, Cereser C, Finco B. Massive rhabdomyolysis and simvastatin. Clin Chem 1992;38:504.
20. Chariot P, Abadia R, Agnus D, Danan C, Charpentier C, Gherardi RK. Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome. Am J Med 1993;94:109-10.
21. Berland Y, Coponat HV, Durand C, Baz M, Laugier R, Musso JL. Rhabdomyolysis with simvastatin use. Nephron 1991;57:365-6.
22. Parke-Davis. Lipitor (atorvastatin calcium) package insert. Morris Plains, NJ;1997.
23. Chow LTC, Chow W. Acute compartment syndrome: an unusual presentation of gemfibrozil induced myositis. Med J Aust 1993;158:48-9.